Steven Jungles

This inventor holds 13 USPTO granted patents and 16 published patent applications, plus 5 CIPO patents and 3 EPO patents. Top assignees: Ultragenyx Pharmaceutical Inc., Biomarin Pharmaceutical Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Jungles. Retrieved from https://idiyas.com/inventor/steven-jungles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 16)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 60(Granted Patents)

Location History:

Naperville, IL (US) (2016 - 2018)
Novato, CA (US) (2009 - 2021)

Company Filing History:

10 out of 34

Ultragenyx Pharmaceutical Inc.

patents

3 out of 137

Biomarin Pharmaceutical Inc.

patents

Years Active: 2009-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551461 - Compositions of triglycerides and uses thereof (2026-02-17),

2. 10889607 - Sialic acid analogs (2021-01-12),

3. 10457701 - Sialic acid analogs (2019-10-29),

4. 10065981 - Sialic acid analogs (2018-09-04),

5. 9937243 - Sialylated glycoprotein compositions and uses thereof (2018-04-10),

6. 9687532 - Sialylated glycoprotein compositons and uses thereof (2017-06-27),

7. 9457068 - Sialylated glycoprotein compositions and uses thereof (2016-10-04),

8. 9457067 - Sialylated glycoprotein compositions and uses thereof (2016-10-04),

9. 9221858 - Sialic acid analogs (2015-12-29),

10. 8840926 - Sialic acid analogs (2014-09-23),

11. 8178670 - Method of synthesizing tetrahydrobiopterin (2012-05-15),

12. 8003126 - Stable tablet formulation (2011-08-23),

13. 7566462 - Stable tablet formulation (2009-07-28),

Title: The Innovations of Steven Jungles

Introduction

Steven Jungles is a notable inventor based in Novato, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sialic acid analogs. With a total of 12 patents to his name, Jungles has established himself as a key figure in addressing sialic acid deficiencies.

Latest Patents

Among his latest patents, Jungles has developed sialic acid analogs that provide compositions useful for the treatment of sialic acid deficiencies. These innovations are crucial for advancing therapeutic options for individuals affected by this condition.

Career Highlights

Throughout his career, Jungles has worked with prominent companies in the pharmaceutical industry, including Ultragenyx Pharmaceutical Inc. and BioMarin Pharmaceutical Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Some of his notable coworkers include Emil D. Kakkis and He Zhao. Their collaborative efforts have further enhanced the impact of Jungles' inventions in the pharmaceutical sector.

Conclusion

Steven Jungles is a distinguished inventor whose work in sialic acid analogs has the potential to transform treatment options for sialic acid deficiencies. His contributions to the pharmaceutical industry are invaluable and continue to inspire future innovations.

Profile summary based on public USPTO records.